News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,670 Results
Type
Article (8018)
Company Profile (140)
Press Release (476511)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166743)
Career Advice (304)
Deals (25740)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238194)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (488)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33161)
ALS (105)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (263)
Approvals (10376)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6963)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (508)
Cancer (3647)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47870)
Collaboration (1245)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (756)
CRISPR (63)
C-suite (747)
Cystic fibrosis (85)
Data (5653)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (343)
Diagnostics (4186)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73715)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87622)
Executive appointments (702)
FDA (12389)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (920)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (951)
Grass and pollen (2)
Guidances (281)
Healthcare (9328)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (536)
Marketing (8)
MASH (118)
Medical device (8655)
Medtech (8800)
Mergers & acquisitions (14386)
Metabolic disorders (706)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1824)
NextGen: Class of 2026 (3153)
Non-profit (846)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (172)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (507)
Peanut (31)
People (41251)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15467)
Phase 2 (21375)
Phase 3 (14401)
Pipeline (7325)
Policy (18)
Postmarket research (1572)
Preclinical (6539)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (571)
Real estate (3021)
Recruiting (6)
Regulatory (14828)
Reports (21)
Research institute (582)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (322)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (10)
Last 7 days (203)
Last 30 days (1546)
Last 365 days (19006)
2026 (12307)
2025 (19251)
2024 (22986)
2023 (26543)
2022 (34592)
2021 (37167)
2020 (33479)
2019 (23256)
2018 (17493)
2017 (18765)
2016 (17920)
2015 (24263)
2014 (21683)
2013 (18135)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17889)
Australia (2098)
California (11969)
Canada (3148)
China (524)
Colorado (484)
Connecticut (409)
Delaware (208)
Europe (24629)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (699)
India (51)
Indiana (314)
Iowa (15)
Japan (399)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1202)
Massachusetts (7854)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2620)
New Mexico (12)
New York (2822)
North Carolina (1278)
North Dakota (4)
Northern California (5996)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4971)
Tennessee (120)
Texas (1940)
United States (38866)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (928)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,670 Results for "ambiopharm inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
CordenPharma inks AmbioPharm buyout to continue peptide production expansion
Swiss service provider CordenPharma is acquiring AmbioPharm, gaining facilities such as a plant in South Carolina to provide a fully U.S.-based supply.
June 1, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
May 27, 2026
·
7 min read
Business
AmbioPharm Appoints Industry Veteran Brian Gregg as CEO
AmbioPharm, a worldwide leader in peptide active pharmaceutical ingredient contract development and manufacturing organization services, announced the appointment of industry veteran Brian Gregg as Chief Executive Officer.
October 2, 2023
·
2 min read
Business
AmbioPharm Provides an Update on South Carolina Headquarters Expansion
AmbioPharm, a worldwide leader in peptide API CDMO services, continues growth to meet capacity demands for late phase and commercial peptide production while increasing our sustainability efforts.
May 17, 2023
·
2 min read
BioMidwest
AmbioPharm to Host a Sustainable Peptide Manufacturing Workshop at Biologics 2023
AmbioPharm, a worldwide leader in peptide API CDMO services, to host a workshop on sustainable peptide manufacturing at Biologics 2023 taking place in London, UK on March 29, 2023.
March 22, 2023
·
2 min read
Business
Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership
Ariceum Therapeutics (Ariceum) and AmbioPharm, a global peptide contract development and manufacturing organization, today announce that they have entered into a strategic partnership for the manufacture and supply of peptide conjugates to be used by Ariceum in future clinical studies.
October 27, 2022
·
3 min read
Drug Development
AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study
AmbioPharm, a global peptide CDMO, is a key partner in peptide manufacturing and development for ONL Therapeutics (ONL), a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease.
July 12, 2022
·
3 min read
Business
CEM Corporation & AmbioPharm Form U.S. Partnership for GMP Peptide Production
CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP peptides for the global market.
September 14, 2021
·
4 min read
BioMidwest
AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members
AmbioPharm Inc., a worldwide leader in peptide API CDMO services, has recently opened its new Shanghai campus.
January 7, 2021
·
1 min read
AmbioPharm Inc. Expands Peptide Production Helping Fight Against Covid-19
AmbioPharm Inc. a leading supplier of peptide active pharmaceutical ingredients has recently opened its new manufacturing and quality control facilities at its headquarters in South Carolina.
June 30, 2020
·
1 min read
1 of 48,467
Next
